Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

← The archive

archived as published

Friday, 25 September · prices through NSE close

PB Fintech shares crash on IRDAI distribution reforms, and 5 more corroborated developments

1

PB Fintech shares crash on IRDAI distribution reforms

PB Fintech shares fell sharply on Thursday, September 24, after the Insurance Regulatory and Development Authority of India proposed significant changes to insurance distribution structures, commissions, and expense management. Insurance stocks across the sector witnessed heavy selling, with declines reported up to 32 percent.

2

PB Fintech shares plunge 36 percent on commission curbs

PB Fintech shares fell 36 percent on Thursday, September 24, erasing more than Rs 31,000 crore from its market capitalisation, after IRDAI proposed changes to insurance distribution commissions and expense limits.

3

Airtel Money files for London Stock Exchange listing

Airtel Money, the payments and fintech arm of Bharti Airtel and Airtel Africa, has filed for a London IPO through an offer for sale by existing shareholders, with no new capital to be raised by the company. The final offer price is expected to be announced in mid-October 2026.

4

IRDAI proposes sweeping insurance sector reforms

The Insurance Regulatory and Development Authority of India has proposed a comprehensive framework of reforms covering insurance distribution, structure, expenses, commissions, market conduct, transparency, and digital infrastructure. The proposals include lower Expenses of Management limits with a five-year glide path to 12.5% for life insurers and 20% for general insurers, tighter controls on commissions linked to product complexity and distribution channel, restrictions on dark patterns, and a framework for Mutual Insurance Intermediaries.

5

Apollo Hospitals appoints Konidela as Director Projects

6

Persistent Systems completes Nagarro stake acquisition

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.